Tofacitinib Prodrug-1
Product Specifications
Target
Others|||Apoptosis|||JAK
Related Pathways
JAK/STAT signaling|||Others|||Tyrosine Kinase/Adaptors|||Apoptosis|||Chromatin/Epigenetic|||Angiogenesis|||Stem Cells
Bioactivity
Tofacitinib Prodrug-1 is an effective and oral active prodrug to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib Prodrug-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib Prodrug-1 is a potential drug candidate for the treatment of ulcerative colitis .
Smiles
C[C@@H]1CCN(C(CC#N)=O)C[C@H]1CNC2=C3C=CN(C(N(CCCNC(OCC4=C(Cl)C=C(N=NC5=CC(C(O)=O)=C(O)C=C5)C=C4)=O)C)=O)C3=NC=N2
Molecular Formula
C36H39ClN10O7
Molecular Weight
759.21
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15195258 1 Vial
Lentiviral mouse Bcdin3d shRNA (UAS) - Lentiviral mouse Bcdin3d shRNA (UAS) (100)
Sign In for Pricing
View Details 
MBS1390230-01 0.02 mg (E-Coli)
Recombinant Staphylococcus epidermidis UPF0355 protein SERP0066 (SERP0066)
Sign In for Pricing
View Details MBS1390230-02 0.1 mg (E-Coli)
Recombinant Staphylococcus epidermidis UPF0355 protein SERP0066 (SERP0066)
Sign In for Pricing
View Details MBS1390230-03 0.02 mg (Yeast)
Recombinant Staphylococcus epidermidis UPF0355 protein SERP0066 (SERP0066)
Sign In for Pricing
View Details